Reduction of butyric acid-producing bacteria in the ileal mucosa-associated microbiota is associated with the history of abdominal surgery in patients with Crohn’s disease

References

• Tsai L, Ma C, Dulai PS, et al. Contemporary risk of surgery in patients with ulcerative colitis and Crohn's disease: a meta-analysis of population-based cohorts. Clin Gastroenterol Hepatol. 2021;19(10):2031–2045.e11. doi:10.1016/j.cgh.2020.10.039.
   PubMed Web of Science ®Google Scholar
• Matsuoka K, Fujii T, Okamoto R, et al. Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD). J Gastroenterol. 2022;57(11):867–878. doi:10.1007/s00535-022-01907-2.
   PubMed Web of Science ®Google Scholar
• Busch K, da Silva SA, Holton M, et al. Sick leave and disability pension in inflammatory bowel disease: a systematic review. J Crohns Colitis. 2014;8(11):1362–77. doi:10.1016/j.crohns.2014.06.006.
   PubMed Web of Science ®Google Scholar
• Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18(1):56–66. doi:10.1038/s41575-020-00360-x.
   PubMed Web of Science ®Google Scholar
• Ko Y, Paramsothy S, Yau Y, et al. Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti-TNF biological agents: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study. Aliment Pharmacol Ther. 2021;54(3):292–301. doi:10.1111/apt.16436.
   PubMed Web of Science ®Google Scholar
• Fukushima S, Shiotani A, Matsumoto H, et al. Comparison of mucosa-associated microbiota in Crohn’s disease patients with and without anti-tumor necrosis factor-α therapy. J Clin Biochem Nutr. 2022;70(2):182–188. doi:10.3164/jcbn.21-41.
   PubMed Web of Science ®Google Scholar
• He C, Wang H, Liao WD, et al. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease. World J Gastroenterol. 2019;25(18):2204–2216. doi:10.3748/wjg.v25.i18.2204.
   PubMed Web of Science ®Google Scholar
• Dulai PS, Singh S, Vande Casteele N, et al. Should We divide Crohn's disease into ileum-dominant and isolated colonic diseases? Clin Gastroenterol Hepatol. 2019;17(13):2634–2643. doi:10.1016/j.cgh.2019.04.040.
   PubMed Web of Science ®Google Scholar
• Takenaka K, Fujii T, Suzuki K, et al. Small bowel healing detected by endoscopy in patients with crohn's disease after treatment with antibodies against tumor necrosis factor. Clin Gastroenterol Hepatol. 2020;18(7):1545–1552. doi:10.1016/j.cgh.2019.08.024.
   PubMed Web of Science ®Google Scholar
• Dicksved J, Halfvarson J, Rosenquist M, et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2008;2(7):716–27. doi:10.1038/ismej.2008.37.
   PubMed Web of Science ®Google Scholar
• Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010;139(6):1844–1854.e1. doi:10.1053/j.gastro.2010.08.049.
   PubMed Web of Science ®Google Scholar
• Hayashi A, Mikami Y, Miyamoto K, et al. Intestinal dysbiosis and biotin deprivation induce alopecia through overgrowth of lactobacillus murinus in mice. Cell Rep. 2017;20(7):1513–1524. doi:10.1016/j.celrep.2017.07.057.
   PubMed Web of Science ®Google Scholar
• Klindworth A, Pruesse E, Schweer T, et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41(1):e1), doi:10.1093/nar/gks808.
   PubMed Web of Science ®Google Scholar
• Gao L, Huang Y, Liu Y, et al. Bacterial community structure and potential microbial coexistence mechanism associated with three halophytes adapting to the extremely hypersaline environment. Microorganisms. 2022 May 30;10(6).
   Web of Science ®Google Scholar
• Janssen S, McDonald D, Gonzalez A, et al. Phylogenetic Placement of exact amplicon sequences improves associations with clinical information. mSystems. 2018;3(3).
   Web of Science ®Google Scholar
• Mukai R, Handa O, Suyama Y, et al. Effectiveness of including probiotics to Helicobacter pylori eradication therapies. J Clin Biochem Nutr. 2020;67(1):102–104. doi:10.3164/jcbn.20-37.
   PubMed Web of Science ®Google Scholar
• Litvak Y, Byndloss MX, Baumler AJ. Colonocyte metabolism shapes the gut microbiota. Science. 2018;362(6418). doi:10.1126/science.aat9076.
   PubMed Web of Science ®Google Scholar
• Wang HB, Wang PY, Wang X, et al. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci. 2012;57(12):3126–35. doi:10.1007/s10620-012-2259-4.
   PubMed Web of Science ®Google Scholar
• Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446–50. doi:10.1038/nature12721.
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Arze C, Ananthakrishnan AN, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–662. doi:10.1038/s41586-019-1237-9.
   PubMed Web of Science ®Google Scholar
• Tomasello G, Mazzola M, Leone A, et al. Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160(4):461–466. doi:10.5507/bp.2016.052.
   PubMed Web of Science ®Google Scholar
• Bourgonje AR, Feelisch M, Faber KN, et al. Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease. Trends Mol Med. 2020;26(11):1034–1046. doi:10.1016/j.molmed.2020.06.006.
   PubMed Web of Science ®Google Scholar
• Marlow G, Ellett S, Ferguson IR, et al. Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients. Hum Genomics. 2013;7(1):24), doi:10.1186/1479-7364-7-24.
   PubMedGoogle Scholar
• Yoshitomi T, Nagasaki Y. Self-Assembling antioxidants for ischemia-reperfusion injuries. Antioxid Redox Signal. 2022;36(1-3):70–80. doi:10.1089/ars.2021.0103.
   PubMed Web of Science ®Google Scholar